Skip to content

Cerebral Palsy: Ankle Foot Orthoses - Footwear Combinations

Biomechanics and Walking in Cerebral Palsy: Ankle Foot Orthoses - Footwear Combinations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03756571
Acronym
CP-AFOFC
Enrollment
21
Registered
2018-11-28
Start date
2018-12-17
Completion date
2021-09-01
Last updated
2021-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy (CP)

Brief summary

Ambulatory children with cerebral palsy (CP) demonstrate altered lower limb biomechanical alignment in walking (e.g. excessive hip/knee flexion or equinus during stance) and experience walking activity limitations that negatively influence their ability to participate in day to day life. Ankle Foot Orthoses (AFO) are a fundamental rehabilitation strategy to facilitate walking in children with CP; yet, a review suggests that efficacy of the traditional solid AFO (TSAFO) in this population remains equivocal. A novel decision tree to guide orthotic prescription proposes a patient-specific method for adjusting AFO alignment and integrating footwear modifications (Ankle Foot Orthoses-Footwear Combinations, AFO-FC). This approach is based on visualizing the sagittal plane orientation of the ground reaction force vector with respect to lower limb segments during gait. The AFO-FC represents a paradigm shift in orthotic management as it accommodates ankle equinus contractures in a rigid AFO, reorients the tibial segment with a heel wedge under the AFO, and applies different heel, midsole and forefoot shoe modifications to restore lost ankle-foot rockers. The primary goal of AFO-FCs are to improve stability by facilitating more normal segment kinematics in single limb stance, decreasing hip/knee flexion. Despite their promise, evidence of an immediate positive effect on midstance alignment is limited, with no evidence of clinical effectiveness. This proposal assesses the feasibility of using a randomized waitlist study to acquire pilot data on a targeted clinical cohort of children with CP evaluating the effectiveness of AFO-FCs as compared to TSAFO during daily life. Individual joint and combined kinematics and kinetics will be examined for potential mechanisms of action as well as daily walking performance, balance and satisfaction with the AFO-FC in 30 ambulatory children with CP, ages 4-9 years, with bilateral crouch or equinus gait pattern, comparing gait in TSAFO to the AFO-FCs.

Detailed description

The goal of this proposal is to assess the feasibility of using a randomized waitlist study to acquire pilot data on a targeted clinical cohort of children with CP evaluating the effectiveness of AFO-FCs as compared to TSAFO during daily life. Individual joint and combined kinematics and kinetics will be examined for potential mechanisms of action as well as daily walking performance, balance and satisfaction with the AFO-FC in 30 ambulatory children with spastic diplegia CP, ages 4-9 years, with bilateral crouch or equinus gait pattern, comparing gait in TSAFO to the AFO-FCs. Aim 1: Examine the effect of AFO-FC on individual joint kinematics, overall gait deviations and walking speed as compared to the TSAFO in children with CP. Multiple gait deviations (e.g. crouch or equinus) in CP result in slow, inefficient walking \[14\]. We hypothesize that the individualized ankle angle, leg segment alignment, and footwear profiles of the AFO-FCs will optimize lower limb joint kinematics, decrease overall gait deviations facilitating longer step lengths (improved stance stability), with resultant increased gait speed as compared to TSAFO. Instrumented gait analysis will assess gait speed and calculate changes in joint specific kinematics with the Gait Profile Score (GPS) and overall combined gait kinematics with the GDI. Aim 2: Examine the effect of AFO-FC on daily walking activity, balance, mobility, and satisfaction as compared to the TSAFO in children with CP. We hypothesize that the AFO-FC will positively affect community walking activity levels, balance, physical activity and satisfaction as compared to the TSAFO. Walking activity will be captured by the StepWatch ® accelerometer; balance by the Pediatric Balance Scale; physical activity by the Patient Reported Outcomes Measurement System (PROMIS®) Pediatric Physical Activity and the Gait Outcomes Assessment List (GOAL); and satisfaction with device by the Orthotic and Prosthetic Users' Survey (OPUS).

Interventions

OTHERAnkle Foot Orthoses-Footwear Combination

This is a solid AFO with angle of ankle in AFO and shoe modifications per algorithm based on physical exam and visual observation of lower extremity kinematics through stance phase of walking.

OTHERTraditional Solid Ankle AFO (TSAFO)

This is a solid ankle AFO with angle of ankle in AFO at 90 degrees or neutral dorsiflexion/plantarflexion.

Sponsors

Orthocare Innovations
CollaboratorINDUSTRY
Hanger Clinic: Prosthetics & Orthotics
CollaboratorOTHER
Cascade Dafo
CollaboratorINDUSTRY
Seattle Children's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Primary outcomes are Gait Profile Score (GPS), Gait Deviation Index (GDI), gait speed from three dimensional gait analysis and community walking activity are all collected via technology (three dimensional gait lab, accelerometry, thus masked.

Intervention model description

Study Design and Randomization. A randomized waitlist trial will be used to compare the AFO-FC to TSAFO in ambulatory children with CP.

Eligibility

Sex/Gender
ALL
Age
4 Years to 9 Years
Healthy volunteers
No

Inclusion criteria

* ambulatory children with spastic diplegia CP, * spasticity primary movement disorder * aged 4-9 years * Gross Motor Function Classification System (GMFCS) levels of II or III * clinically appropriate for a solid AFO based on physical exam/visual gait analysis criteria of: 1. insufficient gastrocnemius length to allow knee extension with ankle dorsiflexion of 10 degrees and an uncompromised foot arch; 2. low tone in the calf muscles with inability to control dorsiflexion during stance; 3. insufficient calf muscle strength to prevent excessive dorsiflexion in stance and create a 'quasi stiff ankle in terminal stance that allows the heel to rise from the ground; and 4. insufficient triplanar boney stability of the foot during stance phase dorsiflexion

Exclusion criteria

* Participants who have undergone: orthopedic or neurological surgery less than 6 months prior to enrollment or injection therapies (phenol, botulinum toxin) less than 3 months prior to enrollment will be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Change in Left Baseline Gait Deviation Index (GDI) at 3 MonthsChange in Right baseline Gait Deviation Index (GDI) at 3 monthsGait Deviation Index (GDI) as a value representing overall gait deviation from a normal kinematic profile (0 to 120 scale) captures cumulative changes occurring at multiple joints and segments by side LEFT/RIGHT. GDI has been shown to have concurrent validity with gross motor function and functional walking levels in children with CP. A score \> 100 is considered in the 'normal' range. A higher score is a better outcome.
Change in Baseline Gait Profile Score (GPS) at 3 Months-individual Lower Extremity Joint Kinematics3 months post wearing assigned orthotic interventionThe Gait Profile Score (GPS) represents the pattern of deviation as a single number and is derived from the same individual joint/limb gait kinematics as Gait Deviation Index (GDI) The GPS minimum value is 0 and maximum value is 20. A higher score is a worse outcome. An minimally clinically important difference is published to be 1.6 for children with CP.
Change in Right Baseline Gait Deviation Index (GDI) at 3 Months3 months post wearing assigned orthotic interventionGait Deviation Index (GDI) as a value representing overall gait deviation from a normal kinematic profile (0 to 120 scale) captures cumulative changes occurring at multiple joints and segments by side left/right. GDI has been shown to have concurrent validity with gross motor function and functional walking levels in children with CP. A score \> 100 is considered in the normal range. A higher score is a better outcome.
Change in Baseline Walking Speed in Meters/Second (m/s) at 3 Months.3 months post wearing assigned orthotic interventionGait speed will be captured during the three dimensional gait analysis testing. Gait speed is measured in meters per second (m/sec) with range from 0 to \ 3.0 m/sec for walking in children. A higher number of m/sec is considered a better outcome with minimally clinically important difference (MCID) of .10 m/s for persons with CP.
Change in Baseline Community Walking Activity Level at 3 Months in Strides/Day.3 months post wearing assigned orthotic interventionCommunity walking activity will be captured by the ankle worn StepWatch ® accelerometer capturing change in average strides/day. The StepWatch ® is a two dimension accelerometer validated to capture when the foot leaves the ground for a metric of stride counts within the context of daily life. Average strides/day can range from 0 to unlimited strides/day. A higher number of strides/day is considered a better outcome.
Change in Baseline Community Walking Intensity at 3 Months in Percent Time in High Stride Rates of > 60 Strides/Minute.3 months post wearing assigned orthotic interventionCommunity walking activity will be captured by the ankle worn StepWatch Accelerometer capturing % time at high stride rates. Percent time at high stride rates (\> 60 strides/min) can range from 0 to 100% with a higher percent considered a better outcome.

Secondary

MeasureTime frameDescription
Change in Balance From Baseline to 3 Months as Measured by Pediatric Balance Scale.3 months post wearing assigned orthotic interventionThe Pediatric Balance Scale (PBS) is a functional measure intended to assess balance in a clinical setting for children with neurological impairment. The PBS is a scaled scoring with range of 0 to 100 with a higher score a better outcome.
Change in Mobility From Baseline to 3 Months Change in Gait Outcome Assessment List (GOAL) Total Standard Score .3 months post wearing assigned orthotic interventionGait Outcomes Assessment List (GOAL) - The Gait Outcomes Assessment List (GOAL) is a outcome assessment to evaluate gait priorities and functional mobility for ambulant children with CP. The GOAL range of standard scores is 0 to 100 with a high score a better outcome. The GOAL will allow clinicians to better understand the motor abilities, priorities, and expectations of ambulant children with CP and to improve decision-making about appropriate interventions. The GOAL consists of 48 items grouped into seven domains: 1) activities of daily living and independence; 2) gait function and mobility; 3) pain, discomfort and fatigue; 4) physical activities, sports and recreation; 5) gait pattern and appearance; 6) use of braces and mobility aids; and 7) body image and self-esteem.
Difference Between Groups in Physical Function T-scores of Patient-Reported Outcomes Measurement Information System (PROMIS) After 3 Months Wearing Devices/Shoes.3 months post wearing assigned orthotic interventionParental report of Physical Function Mobility subscale T-scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric survey. The PROMIS Physical Function subscale T score range is 0 to 100 with a higher score a better outcome. The mean of the T-score for Physical Function Mobility is 50 with a SD of 10, For parental report a score \> or equal to 45 is consider Good, 36 - 44 Fair and \< or equal to 35 Poor physical Function
Difference Between Groups in Pain/Fatigue Level of the Gait Outcomes Assessment List (GOAL) After Wearing Devices/Shoes for 3 Months3 months post wearing assigned orthotic interventionParental report of pain/fatigue domain standard scores on the Gait Outcomes Assessment List (GOAL). The range of the pain/fatigue subscale of the GOAL 0 to 100. A higher score is a better outcome.
Difference Between Groups in Pain Interference After Wearing Devices/Shoes for 3 Months Pain Interference T Scores From PROMIS Pediatric Survey3 months post wearing assigned orthotic interventionParental report of selected pain and pain interference items from the Patient-Reported Outcomes Measurement Information System (PROMIS)pediatric survey. The Pediatric PROMIS pain interference subscale T score range is 0 to 100 with a lower score a better outcome. The mean is 50 with SD of 10. For the Pain interference a T score \< 50 is considered within normal limits.
Difference Between Groups in Satisfaction With Orthoses/Shoes After Wearing for 3 Months Per Orthotic and Prosthetic Users Survey (OPUS).3 months post wearing assigned orthotic interventionParental report of satisfaction raw score items from the Orthotic and Prosthetic Users' Survey (OPUS). The range of OPUS scores is 11-55 with a higher score a better outcome. The raw scores are employed as the survey validation for Rasch scores is not completed for children.

Countries

United States

Participant flow

Recruitment details

All participants were approached and recruited through clinical care at Seattle Children's Hospital (SCH) or regionally by study team, once clinically deemed to meet inclusion criteria.

Pre-assignment details

This was a randomized cross over design where those who randomized to TSAFO group first then crossed over without a washout period to the AFOFC treatment arm after 3 months of wearing the TSAFO.

Participants by arm

ArmCount
Ankle Foot Orthoses-Footwear Combination
The intervention is a Ankle Foot Orthoses Footwear Combination (AFO-FC). This is some form of solid ankle AFO combined with modified footwear individually designed per algorithm. Ankle Foot Orthoses-Footwear Combination: This is a solid AFO with angle of ankle in AFO and shoe modifications per algorithm based on physical exam and visual observation of lower extremity kinematics through stance phase of walking.
9
Traditional Solid Ankle AFO (TSAFO)
The intervention is a solid AFO (SAFO) aligned with the ankle at 90 degrees and worn with regular footwear. We'll refer to this as the traditional SAFO (TSAFO)... Traditional Solid Ankle AFO (TSAFO): This is a solid ankle AFO with angle of ankle in AFO at 90 degrees or neutral dorsiflexion/plantarflexion.
10
Total19

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up11

Baseline characteristics

CharacteristicAnkle Foot Orthoses-Footwear CombinationTotalTraditional Solid Ankle AFO (TSAFO)
Age, Continuous7.3 years6.9 years6.6 years
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants1 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
8 Participants18 Participants10 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants4 Participants3 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants0 Participants
Race (NIH/OMB)
More than one race
1 Participants3 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
6 Participants11 Participants5 Participants
Region of Enrollment
United States
9 Participants19 Participants10 Participants
Sex: Female, Male
Female
2 Participants4 Participants2 Participants
Sex: Female, Male
Male
7 Participants15 Participants8 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 90 / 10
other
Total, other adverse events
5 / 98 / 10
serious
Total, serious adverse events
0 / 90 / 10

Outcome results

Primary

Change in Baseline Community Walking Activity Level at 3 Months in Strides/Day.

Community walking activity will be captured by the ankle worn StepWatch ® accelerometer capturing change in average strides/day. The StepWatch ® is a two dimension accelerometer validated to capture when the foot leaves the ground for a metric of stride counts within the context of daily life. Average strides/day can range from 0 to unlimited strides/day. A higher number of strides/day is considered a better outcome.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationChange in Baseline Community Walking Activity Level at 3 Months in Strides/Day.-804 strides/dayStandard Deviation 1131
Traditional Solid Ankle AFO (TSAFO)Change in Baseline Community Walking Activity Level at 3 Months in Strides/Day.-182 strides/dayStandard Deviation 813
p-value: 0.23t-test, 2 sided
Primary

Change in Baseline Community Walking Intensity at 3 Months in Percent Time in High Stride Rates of > 60 Strides/Minute.

Community walking activity will be captured by the ankle worn StepWatch Accelerometer capturing % time at high stride rates. Percent time at high stride rates (\> 60 strides/min) can range from 0 to 100% with a higher percent considered a better outcome.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationChange in Baseline Community Walking Intensity at 3 Months in Percent Time in High Stride Rates of > 60 Strides/Minute.-.03 percentage of time in > 60 strides/minStandard Deviation 0.24
Traditional Solid Ankle AFO (TSAFO)Change in Baseline Community Walking Intensity at 3 Months in Percent Time in High Stride Rates of > 60 Strides/Minute.-.15 percentage of time in > 60 strides/minStandard Deviation 0.86
p-value: 0.7t-test, 2 sided
Primary

Change in Baseline Gait Profile Score (GPS) at 3 Months-individual Lower Extremity Joint Kinematics

The Gait Profile Score (GPS) represents the pattern of deviation as a single number and is derived from the same individual joint/limb gait kinematics as Gait Deviation Index (GDI) The GPS minimum value is 0 and maximum value is 20. A higher score is a worse outcome. An minimally clinically important difference is published to be 1.6 for children with CP.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationChange in Baseline Gait Profile Score (GPS) at 3 Months-individual Lower Extremity Joint Kinematics0.41 units on a scaleStandard Deviation 1.95
Traditional Solid Ankle AFO (TSAFO)Change in Baseline Gait Profile Score (GPS) at 3 Months-individual Lower Extremity Joint Kinematics-0.48 units on a scaleStandard Deviation 1.47
p-value: 0.36t-test, 2 sided
Primary

Change in Baseline Walking Speed in Meters/Second (m/s) at 3 Months.

Gait speed will be captured during the three dimensional gait analysis testing. Gait speed is measured in meters per second (m/sec) with range from 0 to \ 3.0 m/sec for walking in children. A higher number of m/sec is considered a better outcome with minimally clinically important difference (MCID) of .10 m/s for persons with CP.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationChange in Baseline Walking Speed in Meters/Second (m/s) at 3 Months.-.03 meters/second (m/s)Standard Deviation 18
Traditional Solid Ankle AFO (TSAFO)Change in Baseline Walking Speed in Meters/Second (m/s) at 3 Months..13 meters/second (m/s)Standard Deviation 0.16
p-value: 0.15t-test, 2 sided
Primary

Change in Left Baseline Gait Deviation Index (GDI) at 3 Months

Gait Deviation Index (GDI) as a value representing overall gait deviation from a normal kinematic profile (0 to 120 scale) captures cumulative changes occurring at multiple joints and segments by side LEFT/RIGHT. GDI has been shown to have concurrent validity with gross motor function and functional walking levels in children with CP. A score \> 100 is considered in the 'normal' range. A higher score is a better outcome.

Time frame: Change in Right baseline Gait Deviation Index (GDI) at 3 months

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationChange in Left Baseline Gait Deviation Index (GDI) at 3 Months-1.5 units on a scaleStandard Deviation 2.7
Traditional Solid Ankle AFO (TSAFO)Change in Left Baseline Gait Deviation Index (GDI) at 3 Months1.3 units on a scaleStandard Deviation 6.1
p-value: 0.33t-test, 2 sided
Primary

Change in Right Baseline Gait Deviation Index (GDI) at 3 Months

Gait Deviation Index (GDI) as a value representing overall gait deviation from a normal kinematic profile (0 to 120 scale) captures cumulative changes occurring at multiple joints and segments by side left/right. GDI has been shown to have concurrent validity with gross motor function and functional walking levels in children with CP. A score \> 100 is considered in the normal range. A higher score is a better outcome.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationChange in Right Baseline Gait Deviation Index (GDI) at 3 Months.07 units on a scaleStandard Deviation 10.2
Traditional Solid Ankle AFO (TSAFO)Change in Right Baseline Gait Deviation Index (GDI) at 3 Months3.2 units on a scaleStandard Deviation 5.8
p-value: 0.5t-test, 2 sided
Secondary

Change in Balance From Baseline to 3 Months as Measured by Pediatric Balance Scale.

The Pediatric Balance Scale (PBS) is a functional measure intended to assess balance in a clinical setting for children with neurological impairment. The PBS is a scaled scoring with range of 0 to 100 with a higher score a better outcome.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationChange in Balance From Baseline to 3 Months as Measured by Pediatric Balance Scale.12.8 score on a scaleStandard Deviation 10.5
Traditional Solid Ankle AFO (TSAFO)Change in Balance From Baseline to 3 Months as Measured by Pediatric Balance Scale.3.5 score on a scaleStandard Deviation 5.8
p-value: 0.03Regression, Linear
Secondary

Change in Mobility From Baseline to 3 Months Change in Gait Outcome Assessment List (GOAL) Total Standard Score .

Gait Outcomes Assessment List (GOAL) - The Gait Outcomes Assessment List (GOAL) is a outcome assessment to evaluate gait priorities and functional mobility for ambulant children with CP. The GOAL range of standard scores is 0 to 100 with a high score a better outcome. The GOAL will allow clinicians to better understand the motor abilities, priorities, and expectations of ambulant children with CP and to improve decision-making about appropriate interventions. The GOAL consists of 48 items grouped into seven domains: 1) activities of daily living and independence; 2) gait function and mobility; 3) pain, discomfort and fatigue; 4) physical activities, sports and recreation; 5) gait pattern and appearance; 6) use of braces and mobility aids; and 7) body image and self-esteem.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationChange in Mobility From Baseline to 3 Months Change in Gait Outcome Assessment List (GOAL) Total Standard Score .7.91 score on a scaleStandard Deviation 9.2
Traditional Solid Ankle AFO (TSAFO)Change in Mobility From Baseline to 3 Months Change in Gait Outcome Assessment List (GOAL) Total Standard Score .-0.44 score on a scaleStandard Deviation 5.5
p-value: 0.03Regression, Linear
Secondary

Difference Between Groups in Pain/Fatigue Level of the Gait Outcomes Assessment List (GOAL) After Wearing Devices/Shoes for 3 Months

Parental report of pain/fatigue domain standard scores on the Gait Outcomes Assessment List (GOAL). The range of the pain/fatigue subscale of the GOAL 0 to 100. A higher score is a better outcome.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationDifference Between Groups in Pain/Fatigue Level of the Gait Outcomes Assessment List (GOAL) After Wearing Devices/Shoes for 3 Months88.3 score on a scaleStandard Deviation 12.2
Traditional Solid Ankle AFO (TSAFO)Difference Between Groups in Pain/Fatigue Level of the Gait Outcomes Assessment List (GOAL) After Wearing Devices/Shoes for 3 Months78.2 score on a scaleStandard Deviation 16.7
p-value: 0.18t-test, 2 sided
Secondary

Difference Between Groups in Pain Interference After Wearing Devices/Shoes for 3 Months Pain Interference T Scores From PROMIS Pediatric Survey

Parental report of selected pain and pain interference items from the Patient-Reported Outcomes Measurement Information System (PROMIS)pediatric survey. The Pediatric PROMIS pain interference subscale T score range is 0 to 100 with a lower score a better outcome. The mean is 50 with SD of 10. For the Pain interference a T score \< 50 is considered within normal limits.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationDifference Between Groups in Pain Interference After Wearing Devices/Shoes for 3 Months Pain Interference T Scores From PROMIS Pediatric Survey45.6 T scoreStandard Deviation 8.6
Traditional Solid Ankle AFO (TSAFO)Difference Between Groups in Pain Interference After Wearing Devices/Shoes for 3 Months Pain Interference T Scores From PROMIS Pediatric Survey53.4 T scoreStandard Deviation 13.1
p-value: 0.15t-test, 2 sided
Secondary

Difference Between Groups in Physical Function T-scores of Patient-Reported Outcomes Measurement Information System (PROMIS) After 3 Months Wearing Devices/Shoes.

Parental report of Physical Function Mobility subscale T-scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric survey. The PROMIS Physical Function subscale T score range is 0 to 100 with a higher score a better outcome. The mean of the T-score for Physical Function Mobility is 50 with a SD of 10, For parental report a score \> or equal to 45 is consider Good, 36 - 44 Fair and \< or equal to 35 Poor physical Function

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationDifference Between Groups in Physical Function T-scores of Patient-Reported Outcomes Measurement Information System (PROMIS) After 3 Months Wearing Devices/Shoes.36.2 T scoreStandard Deviation 3.8
Traditional Solid Ankle AFO (TSAFO)Difference Between Groups in Physical Function T-scores of Patient-Reported Outcomes Measurement Information System (PROMIS) After 3 Months Wearing Devices/Shoes.32.9 T scoreStandard Deviation 3.9
p-value: 0.08t-test, 2 sided
Secondary

Difference Between Groups in Satisfaction With Orthoses/Shoes After Wearing for 3 Months Per Orthotic and Prosthetic Users Survey (OPUS).

Parental report of satisfaction raw score items from the Orthotic and Prosthetic Users' Survey (OPUS). The range of OPUS scores is 11-55 with a higher score a better outcome. The raw scores are employed as the survey validation for Rasch scores is not completed for children.

Time frame: 3 months post wearing assigned orthotic intervention

ArmMeasureValue (MEAN)Dispersion
Ankle Foot Orthoses-Footwear CombinationDifference Between Groups in Satisfaction With Orthoses/Shoes After Wearing for 3 Months Per Orthotic and Prosthetic Users Survey (OPUS).42.1 score on a scaleStandard Deviation 6.9
Traditional Solid Ankle AFO (TSAFO)Difference Between Groups in Satisfaction With Orthoses/Shoes After Wearing for 3 Months Per Orthotic and Prosthetic Users Survey (OPUS).42.8 score on a scaleStandard Deviation 4.7
p-value: 0.8t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026